REQUEST A DEMO
Total
USD $0.00
Search more companies

Gilead Sciences Korea Limited (Seoul) (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Gilead Sciences Korea Limited Profile Updated: October 27, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Gilead Sciences Korea Limited (Seoul) is based in South Korea. The head office is in Seoul. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Gilead Sciences Korea Limited (Seoul) was incorporated on March 11, 2011. The total number of employees is currently 83 (2023). From the latest financial highlights, Gilead Sciences Korea Limited (Seoul) reported a net sales revenue increase of 96.08% in 2022. Its total assets grew by 61.36% over the same period. The net profit margin of Gilead Sciences Korea Limited (Seoul) increased by 0.13% in 2022.

Headquarters
15th Floor, 26, Eulji-ro 5-gil Jung-gu Seoul
Seoul; Seoul; Postal Code: 100210

Contact Details: Purchase the Gilead Sciences Korea Limited (Seoul) report to view the information.

Website: http://www.gilead.co.kr

Basic Information
Total Employees:
Purchase the Gilead Sciences Korea Limited (Seoul) report to view the information.
Outstanding Shares:
Purchase the Gilead Sciences Korea Limited (Seoul) report to view the information.
Registered Capital:
Purchase the Gilead Sciences Korea Limited (Seoul) report to view the information.
Incorporation Date:
March 11, 2011
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Gilead Sciences Korea Limited (Seoul) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
96.08%
Total operating revenue
96.08%
Operating profit (EBIT)
84.12%
EBITDA
83.89%
Net Profit (Loss) for the Period
104.49%
Total assets
61.36%
Total equity
5.53%
Operating Profit Margin (ROS)
-0.27%
Net Profit Margin
0.13%
Return on Equity (ROE)
19.04%
Quick Ratio
0.11%
Cash Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?